Interleukin-36 Receptor Antagonist Protein (IL36RN) Antibody

Este producto es parte de IL36RN - Interleukin-36 receptor antagonist protein
Product Graph
169€ (20 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Interleukin-36 Receptor Antagonist Protein (IL36RN) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx320513
tested applications
ELISA, IHC

Description

IL36RN Antibody is a Rabbit Polyclonal against IL36RN.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Interleukin-36 Receptor Antagonist Protein (IL36RN)
Host
Rabbit
Reactivity
Human
Recommended Dilution
IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
20 µl
Size 2
50 µl
Size 3
100 µl
Size 4
200 µl
Size 5
1 ml
Form
Liquid
Tested Applications
ELISA, IHC
Buffer
PBS, pH 7.3, containing 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9UBH0
Gene ID
26525
OMIM
605507
Alias
IL-36Ra,IL-1F5,FIL1, FIL1Delta,IL1F5
Background
Antibody anti-IL36RN
Status
RUO
Note
Concentration: 0.44 mg/ml - 

Descripción

IL36RN, also known as IL-36Ra, is an anti-inflammatory cytokine that functions as a natural inhibitor of IL-36 signaling. It binds to the IL-36 receptor (IL1RL2) and prevents its activation by IL36A, IL36B, and IL36G, thereby blocking downstream NF-κB, MAPK, and JNK signaling pathways. IL36RN is primarily expressed in keratinocytes, epithelial cells, and immune cells, where it regulates inflammation and prevents excessive immune activation at epithelial barriers. It plays a key role in maintaining tissue homeostasis and limiting pathological inflammation in conditions such as psoriasis, where mutations in IL36RN lead to uncontrolled IL-36 activity, severe inflammation, and pustular psoriasis. IL36RN is also implicated in mucosal immunity and inflammatory diseases of the skin, lungs, and gastrointestinal tract. Knockout studies reveal heightened IL-36 signaling, excessive cytokine production, and severe tissue inflammation, underscoring IL36RN's role as a key anti-inflammatory regulator and protective factor in immune homeostasis and barrier tissue health.

Related Products

EH5010

Human IL36RN (Interleukin-36 receptor antagonist protein) ELISA Kit

Ver Producto
FNab04238

IL36RN antibody

Ver Producto
P1161

Recombinant Mouse IL36RN

Ver Producto